Increased serum oxysterol concentrations in patients with chronic hepatitis C virus infection

Biochemical and Biophysical Research Communications

Volumn 446, Issue 3, 2014, Pages 736-740

  Ikegami, Tadashi ^a   Honda, Akira ^a   Miyazaki, Teruo ^a   Kohjima, Motoyuki ^b   Nakamuta, Makoto ^b   Matsuzaki, Yasushi ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION   (Japan)

Author keywords

Anti viral therapy; Chronic hepatitis C virus infection; Oxysterol

Indexed keywords

22 HYDROXYCHOLESTEROL; 24S HYDROXYCHOLESTEROL; 25 HYDROXYCHOLESTEROL; 26 HYDROXYCHOLESTEROL; 4 BETA HYDROXYCHOLESTEROL; 7ALPHA HYDROXYCHOLESTEROL; OXYSTEROL; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RIBAVIRIN; UNCLASSIFIED DRUG;

ADULT; ANTIVIRAL THERAPY; ARTICLE; AUTOOXIDATION; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; HEPATITIS C; HUMAN; LIQUID CHROMATOGRAPHY; LIVER CARCINOGENESIS; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY;

ANTI-VIRAL THERAPY; CHRONIC HEPATITIS C VIRUS INFECTION; OXYSTEROL;

ANTIVIRAL AGENTS; CASE-CONTROL STUDIES; FEMALE; HEPATITIS C, CHRONIC; HUMANS; HYDROXYCHOLESTEROLS; INTERFERON-ALPHA; MALE; MIDDLE AGED; OXIDATIVE STRESS; POLYETHYLENE GLYCOLS; RECOMBINANT PROTEINS; RIBAVIRIN; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY;

EID: 84898771211     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.01.176     Document Type: Article

References (38)

1. A.J. Brown, and W. Jessup Oxysterols and atherosclerosis Atherosclerosis 142 1999 1 28
2. D. Alkazemi, G. Egeland, J. Vaya, S. Meltzer, and S. Kubow Oxysterol as a marker of atherogenic dyslipidemia in adolescence J. Clin. Endocrinol Metab. 93 2008 4282 4289
3. D.M. van Reyk, A.J. Brown, L.M. Hult'en, R.T. Dean, and W. Jessup Oxysterols in biological systems: sources, metabolism and pathophysiological relevance Redox Rep. 11 2006 255 262
4. L. Malvitte, T. Montange, C. Joffre, A. Vejux, C. Maiza, A. Bron, C. Creuzot-Garcher, and G. Lizard Analogies between atherosclerosis and age-related maculopathy: expected roles of oxysterols J. Fr. Ophtalmol. 29 2006 570 578
5. V. Leoni Oxysterols as markers of neurological disease-a review Scand. J. Clin. Lab. Invest. 69 2009 22 25
6. H. Kolsch, D. Lutjohann, K. von Bergmann, and R. Heun The role of 24S-hydroxycholesterol in Alzheimer's disease J. Nutr. Health Aging 7 2003 37 41
7. H. Liu, L. Yuan, S. Xu, K. Wang, and T. Zhang Cholestane-3beta,5alpha, 6beta-triol inhibits osteoblastic differentiation and promotes apoptosis of rat bone marrow stromal cells J. Cell. Biochem. 96 2005 198 208
8. E.R. Nelson, C.D. DuSell, X. Wang, M.K. Howe, G. Evans, R.D. Michalek, M. Umetani, J.C. Rathmell, S. Khosla, D. Gesty-Palmer, and D.P. McDonnell The oxysterol, 27-hydroxycholesterol, links cholesterol metabolism to bone homeostasis through its actions on the estrogen and liver X receptors Endocrinology 152 2011 4691 4705
9. F. Biasi, C. Mascia, M. Astegiano, E. Chiarpotto, M. Nano, B. Vizio, G. Leonarduzzi, and G. Poli Pro-oxidant and proapoptotic effects of cholesterol oxidation products on human colonic epithelial cells: a potential mechanism of inflammatory bowel disease progression Free Radic. Biol. Med. 47 2009 1731 1741
10. A. Jusakul, W. Loilome, N. Namwat, W.G. Haigh, R. Kuver, S. Dechakhamphu, P. Sukontawarin, S. Pinlaor, S.P. Lee, and P. Yongvanit Liver fluke-induced hepatic oxysterols stimulate DNA damage and apoptosis in cultured human cholangiocytes Mutat. Res. 731 2012 48 57
11. U.Z. Paracha, K. Fatima, M. Alqahtani, A. Chaudhary, A. Abuzenadah, G. Damanhouri, and I. Qadri Oxidative stress and hepatitis C virus Virol. J. 10 2013 251
12. A.V. Ivanov, B. Bartosch, O.A. Smirnova, M.G. Isaguliants, and S.N. Kochetkov HCV and oxidative stress in the liver Viruses 5 2013 439 469
13. T. Yoshida, Y. Matsuzaki, W.G. Haigh, S. Fukushima, K. Ikezawa, N. Tanaka, and S.P. Lee Origin of oxysterols in hepatic bile of patients with biliary infection Am. J. Gastroenterol. 98 2003 2275 2280
14. T. Ikegami, H. Hyogo, A. Honda, T. Miyazaki, K. Tokushige, E. Hashimoto, K. Inui, Y. Matsuzaki, and S. Tazuma Increased serum liver X receptor ligand oxysterols in patients with non-alcoholic fatty liver disease J. Gastroenterol. 47 2012 1257 1266
15. A. Honda, K. Yamashita, H. Miyazaki, M. Shirai, T. Ikegami, G. Xu, M. Numazawa, T. Hara, and Y. Matsuzaki Highly sensitive analysis of sterol profiles in human serum by LC-ESI-MS/MS J. Lipid Res. 49 2008 2063 2073
16. A. Honda, K. Yamashita, T. Hara, T. Ikegami, T. Miyazaki, M. Shirai, G. Xu, M. Numazawa, and Y. Matsuzaki Highly sensitive quantification of key regulatory oxysterols in biological samples by LC-ESI-MS/MS J. Lipid Res. 50 2009 350 357
17. A. Honda, T. Miyazaki, T. Ikegami, J. Iwamoto, K. Yamashita, M. Numazawa, and Y. Matsuzaki Highly sensitive and specific analysis of sterol profiles in biological samples by HPLC-ESI-MS/MS J. Steroid Biochem. Mol. Biol. 121 2010 556 564
18. A. Honda, K. Yamashita, M. Numazawa, T. Ikegami, M. Doy, Y. Matsuzaki, and H. Miyazaki Highly sensitive quantification of 7α-hydroxy-4-cholesten- 3-one in human serum by LC-ESI-MS/MS J. Lipid Res. 48 2007 458 464
19. F. Ichida, T. Tsuji, and M. Omata New Inuyama Classification for histological assessment of chronic hepatitis Hepatol. Commun. 6 1996 112 119
20. M.F. Bassendine, D.A. Sheridan, S.H. Bridge, D.J. Felmlee, and R.D. Neely Lipids and HCV Semin. Immunopathol. 35 2013 87 100
21. T. Miyazaki, A. Honda, T. Ikegami, Y. Saitoh, T. Hirayama, T. Hara, M. Doy, and Y. Matsuzaki Hepatitis C virus infection causes hypolipidemia regardless of hepatic damage or nutritional state: An epidemiological survey of a large Japanese cohort Hepatol. Res. 41 2011 530 541
22. I. Björkhem, and U. Diczfalusy Oxysterols: friends, foes, or just fellow passengers? Arterioscler. Thromb. Vasc. 22 2002 734 742
23. I. Björkhem Are side-chain oxidized oxysterols regulators also in vivo? J. Lipid Res. 50 Suppl 2009 S213 S218
24. A. Jusakul, P. Yongvanit, W. Loilome, N. Namwat, and R. Kuver Mechanisms of oxysterol-induced carcinogenesis Lipids Health Dis. 10 2011 44
25. A. Honda, T. Miyazaki, T. Ikegami, J. Iwamoto, T. Maeda, T. Hirayama, Y. Saito, T. Teramoto, and Y. Matsuzaki Cholesterol 25-hydroxylation activity of CYP3A J. Lipid Res. 52 2011 1509 1516
26. R.P. Patel, U. Diczfalusy, S. Dzeletovic, M.T. Wilson, and V.M. Darley-Usmar Formation of oxysterols during oxidation of low density lipoprotein by peroxynitrite, myoglobin, and copper J. Lipid Res. 37 1996 2361 2371
27. O. Breuer, S. Dzeletovic, E. Lund, and U. Diczfalusy The oxysterols cholest-5-ene-3β,4α-diol, cholest-5-ene-3β,4β-diol and cholestane-3β,5α,6α-triol are formed during in vitro oxidation of low density lipoprotein, and are present in human atherosclerotic plaques Biochim. Biophys. Acta 1302 1996 145 152
28. L. Smith Cholesterol Autoxidation 1981 Plenum Press New York and London
29. M. Arciello, S. Petta, V. Leoni, G. Iannucci, G. Labbadia, C. Camma, A. Craxi, and C. Balsano Inverse correlation between plasma oxysterol and LDL-cholesterol levels in hepatitis C virus-infected patients Dig. Liver Dis. 44 2012 245 250
30. M. Axelson, I. Bjorkhem, E. Reihner, and K. Einarsson The plasma level of 7α-hydroxy-4-cholesten-3-one reflects the activity of hepatic cholesterol 7α-hydroxylase in man FEBS Lett. 284 1991 216 218
31. A. Honda, T. Yoshida, G. Xu, Y. Matsuzaki, S. Fukushima, N. Tanaka, M. Doy, S. Shefer, and G. Salen Significance of plasma 7α-hydroxy-4- cholesten-3-one and 27-hydroxycholesterol concentrations as markers for hepatic bile acid synthesis in cholesterol-fed rabbits Metabolism 53 2004 42 48
32. L. Becquemont, O. Chazouilleres, L. Serfaty, J.M. Poirier, F. Broly, P. Jaillon, R. Poupon, and C. Funck-Brentano Effect of interferon alpha-ribavirin bitherapy on cytochrome P450 1A2 and 2D6 and N-acetyltransferase-2 activities in patients with chronic active hepatitis C Clin. Pharmacol. Ther. 71 2002 488 495
33. P.N. Morcos, S.A. Moreira, B.J. Brennan, S. Blotner, N.S. Shulman, and P.F. Smith Influence of chronic hepatitis C infection on cytochrome P450 3A4 activity using midazolam as an in vivo probe substrate Eur. J. Clin. Pharmacol. 69 2013 1777 1784
34. B.J. Brennan, Z.X. Xu, and J.F. Grippo Effect of peginterferon alfa-2a (40KD) on cytochrome P450 isoenzyme activity Brit. J. Clin. Pharmacol. 75 2013 497 506
35. D.R. Bauman, A.D. Bitmansour, J.G. McDonald, B.M. Thompson, G. Liang, and D.W. Russell 25-Hydroxycholesterol secreted by macrophages in response to Toll-like receptor activation suppresses immunoglobulin A production Proc. Natl. Acad. Sci. USA 106 2009 16764 16769
36. U. Diczfalusy, K.E. Olofsson, A.M. Carlsson, M. Gong, D.T. Golenbock, O. Rooyackers, U. Fläring, and H. Björkbacka Marked upregulation of cholesterol 25-hydroxylase expression by lipopolysaccharide J. Lipid Res. 50 2009 2258 2264
37. S.Y. Liu, R. Aliyari, K. Chikere, G. Li, M.D. Marsden, J.K. Smith, O. Pernet, H. Guo, R. Nusbaum, J.A. Zack, A.N. Freiberg, L. Su, B. Lee, and G. Cheng Interferon-inducible cholesterol-25-hydroxylase broadly inhibits viral entry by production of 25-hydroxycholesterol Immunity 38 2013 92 105
38. E.G. Lund, T.A. Kerr, J. Sakai, W.P. Li, and D.W. Russell CDNA cloning of mouse and human cholesterol 25-hydroxylases, polytopic membrane proteins that synthesize a potent oxysterol regulator of lipid metabolism J. Biol. Chem. 273 1998 34316 34327